NPHP3_XENLA
ID NPHP3_XENLA Reviewed; 1300 AA.
AC Q6AZT7;
DT 05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT 13-SEP-2004, sequence version 1.
DT 03-AUG-2022, entry version 78.
DE RecName: Full=Nephrocystin-3;
GN Name=nphp3;
OS Xenopus laevis (African clawed frog).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX NCBI_TaxID=8355;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC TISSUE=Ovary;
RG NIH - Xenopus Gene Collection (XGC) project;
RL Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN [2]
RP FUNCTION.
RX PubMed=18371931; DOI=10.1016/j.ajhg.2008.02.017;
RA Bergmann C., Fliegauf M., Bruechle N.O., Frank V., Olbrich H.,
RA Kirschner J., Schermer B., Schmedding I., Kispert A., Kraenzlin B.,
RA Nuernberg G., Becker C., Grimm T., Girschick G., Lynch S.A., Kelehan P.,
RA Senderek J., Neuhaus T.J., Stallmach T., Zentgraf H., Nuernberg P.,
RA Gretz N., Lo C., Lienkamp S., Schaefer T., Walz G., Benzing T., Zerres K.,
RA Omran H.;
RT "Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-
RT Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic
RT dysplasia.";
RL Am. J. Hum. Genet. 82:959-970(2008).
RN [3]
RP DISRUPTION PHENOTYPE.
RX PubMed=23793029; DOI=10.1038/ng.2681;
RA Hoff S., Halbritter J., Epting D., Frank V., Nguyen T.M., van Reeuwijk J.,
RA Boehlke C., Schell C., Yasunaga T., Helmstadter M., Mergen M., Filhol E.,
RA Boldt K., Horn N., Ueffing M., Otto E.A., Eisenberger T., Elting M.W.,
RA van Wijk J.A., Bockenhauer D., Sebire N.J., Rittig S., Vyberg M., Ring T.,
RA Pohl M., Pape L., Neuhaus T.J., Elshakhs N.A., Koon S.J., Harris P.C.,
RA Grahammer F., Huber T.B., Kuehn E.W., Kramer-Zucker A., Bolz H.J.,
RA Roepman R., Saunier S., Walz G., Hildebrandt F., Bergmann C.,
RA Lienkamp S.S.;
RT "ANKS6 is a central component of a nephronophthisis module linking NEK8 to
RT INVS and NPHP3.";
RL Nat. Genet. 45:951-956(2013).
CC -!- FUNCTION: Required for normal ciliary development and function.
CC Inhibits disheveled-1-induced canonical Wnt-signaling activity and may
CC also play a role in the control of non-canonical Wnt signaling that
CC regulates planar cell polarity. Probably acts as a molecular switch
CC between different Wnt signaling pathways. Required for proper
CC convergent extension cell movements. {ECO:0000269|PubMed:18371931}.
CC -!- SUBCELLULAR LOCATION: Cell projection, cilium {ECO:0000250}.
CC -!- DISRUPTION PHENOTYPE: Bilateral morpholino knockdown of the protein in
CC the embryo causes gross body edema that is typical of a renal excretory
CC defect. {ECO:0000269|PubMed:23793029}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; BC077320; AAH77320.1; -; mRNA.
DR RefSeq; NP_001086695.1; NM_001093226.1.
DR AlphaFoldDB; Q6AZT7; -.
DR SMR; Q6AZT7; -.
DR MaxQB; Q6AZT7; -.
DR DNASU; 446530; -.
DR GeneID; 446530; -.
DR KEGG; xla:446530; -.
DR CTD; 446530; -.
DR Xenbase; XB-GENE-865745; nphp3.L.
DR OrthoDB; 377554at2759; -.
DR Proteomes; UP000186698; Chromosome 6L.
DR Bgee; 446530; Expressed in pancreas and 19 other tissues.
DR GO; GO:0005929; C:cilium; ISS:UniProtKB.
DR GO; GO:0060271; P:cilium assembly; ISS:UniProtKB.
DR GO; GO:0060027; P:convergent extension involved in gastrulation; IMP:BHF-UCL.
DR GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISS:UniProtKB.
DR GO; GO:2000095; P:regulation of Wnt signaling pathway, planar cell polarity pathway; IMP:UniProtKB.
DR GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR Gene3D; 1.25.40.10; -; 3.
DR Gene3D; 3.40.50.300; -; 1.
DR InterPro; IPR027417; P-loop_NTPase.
DR InterPro; IPR011990; TPR-like_helical_dom_sf.
DR InterPro; IPR019734; TPR_repeat.
DR Pfam; PF13176; TPR_7; 1.
DR SMART; SM00028; TPR; 8.
DR SUPFAM; SSF48452; SSF48452; 2.
DR SUPFAM; SSF52540; SSF52540; 1.
DR PROSITE; PS50005; TPR; 8.
DR PROSITE; PS50293; TPR_REGION; 1.
PE 2: Evidence at transcript level;
KW Cell projection; Cilium; Coiled coil; Reference proteome; Repeat;
KW TPR repeat; Wnt signaling pathway.
FT CHAIN 1..1300
FT /note="Nephrocystin-3"
FT /id="PRO_0000106303"
FT REPEAT 443..476
FT /note="TPR 1"
FT REPEAT 916..949
FT /note="TPR 2"
FT REPEAT 958..991
FT /note="TPR 3"
FT REPEAT 1000..1033
FT /note="TPR 4"
FT REPEAT 1066..1099
FT /note="TPR 5"
FT REPEAT 1108..1141
FT /note="TPR 6"
FT REPEAT 1150..1183
FT /note="TPR 7"
FT REPEAT 1192..1225
FT /note="TPR 8"
FT REPEAT 1234..1267
FT /note="TPR 9"
FT REGION 1268..1288
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COILED 82..183
FT /evidence="ECO:0000255"
FT COMPBIAS 1273..1288
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 1300 AA; 148319 MW; 8EAE11EDBF8E5ED2 CRC64;
MGTASSLVNA GEVIEDTYGG GGGEDCVIPV EVKPKARLLR SSFRRGPRVI GASFKSTASV
DLEYAAEYER LKKEYEIFRV SKNNEVASMQ KKEIKLDEEN KRLRAELQAL QKTYQKILRE
KESAVEAKYQ AMERAATFEH DRDKVKRQFK IFRETKEKEI QDLLRAKRDL EAKLQRLQAQ
GIQVFDPGES DSDDNGTEVT VPSTQCEYWT SGALGSDPSM GSMMQLQQSF RGPEFAHSSI
DVEGPFANVN RDDWDAAVAS LLQVTPLFSQ SLWSNTVRCY LMSTAETQAE VEIFLRDYSP
KLQRMCETSG YFFQMVFFPE ECESQHFAVR KWEIEKSSIV ILFICSSLPS CLQEDCEEAF
LKNNEAKPRL IYHSIEDGRS DSDGLKQLLE QDTNKANKTK VVDHCGDPVE GAYKLYCHLE
QVIKQDLLGI EISDPDAKDE SATMEDDDYG DVLWDVHDEQ EQMEAYQQAS QSICELGFQK
YYDRLNDLVA APAPIPPLLI SGGPGSGKSL LLSKWIQLQQ KHSPNTLMLY HFVGRPLSSS
SEPSLIIKRL TLKLMQHSWS VSSLSMDPGK FLEEFPHWLE KLSIRYQGNI IIIIDSIDHI
QQSEKHMKWL IDPLPVNVRV IVSVNVETCP QAWRLWPTLH LDPLNSKDVK ALINMECGGA
NILLTKEQER KLERHCRSAT TCNALYVTLI TKLLTWAGST GKIEDVLQQC LQCQDTVSLY
RLVLRSVQEV MPSAKEKEFM REILCFISVS HNGVSECELM ELCPGLTWEV LTSLIYHLYT
LVLLKYTCGL LQFQHLQAWD AVNLEYMQGG QNIISEYREK IIKHFTTQLS HDRVTWRSAD
ELTWLFQQQG EKQKLHKCLM NLFVSQNLYK RGHFAELLSY WQLVGKDKIS MASEYFDALK
QYEKNCEGEE KMTSLADLYE TLGRFLKDLG LLSQAVTPLQ RSLEIRETAL DPDHPSVAQS
LHQLAGVYMQ SKKFGNAEQL YKQALEISEN AYGSEHLRVA RELDALAVLY QKQNKFEQAE
QLRKKSLKIR QKSARRKGSM YGFALLRRRA LQLEELTLGK DTSDNARTLN ELGVLYYLQN
NLETAETFLK RSLEMRERVL GADHPDCAQS INNLAALYNE KKQYDKAEEL YERALDIRRR
ALSPDHPSLA YTVKHLAVLY KRKGKLDKAV PLYELAVDIR QKSFGPKHPS VATALVNLAV
LYCQMKKQDD ALPLYERAMK IYEDSLGRMH PRVGETLKNL AVLRYEEGDY EKAAELYKRA
MEIKETETSV LGAKAPSGHS SSGGDTYSVQ NTLPVSVFPE